RxDoctor Payments Data

Christopher Sendi

Emergency Medicine · Farmville, VANPI 1295714475

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (55.9%), speaking fees and education — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Alkermes, Inc. at 40.3% of the total. Among emergency medicine clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,614in general payments, 2019–2025

Across 112 payments — averaging $32.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$1K
  • AbbVie$526
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$402
  • Takeda Pharmaceuticals U.S.A., Inc.$279
  • Vanda Pharmaceuticals Inc.$263
  • Axsome Therapeutics, Inc.$200
  • plus $489 from 11 others

What the payments were for

  • Speaking & faculty fees$1,44040%
  • Food & beverage$2,01956%
  • Education$1564%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,614 in reported general payments places this provider in the 95th percentile of 1,279 emergency medicine providers in Virginia.

See all emergency medicine providers in Virginia

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxymorphone Hcl ErOxymorphone Hcl11$8,997
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl21$1,841
Morphine Sulfate24$500
Oxycodone Hcl12$489
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine24$368
Ondansetron OdtOndansetron35$316
Gabapentin28$270
Alprazolam38$212
Morphine Sulfate ErMorphine Sulfate27$178
Lorazepam11$37
Trazodone Hcl11$4

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Hikma Pharmaceuticals USABuprenorphine-Naloxone, Morphine Sulfate$61$2,34245 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,279 emergency medicine providers in Virginia.

Other emergency medicine in Farmville

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →